Skip to main content
SpringerLink
Log in

Antidepressiva

  • Chapter
  • First Online:
Kompendium der Psychiatrischen Pharmakotherapie

  • 9418 Accesses

Zusammenfassung

Indikationen, Wirkungsweise, Nebenwirkungen und Risiken, Kontraindikationen und Interaktionen werden einmal im allgemeinen Teil und dann für jedes Antidepressivum spezifisch im Präparateteil beschrieben. Jedes Präparat wird bewertet. In einem eigenen Abschnitt werden die Unterschiede der Antidepressiva in Bezug auf Wirksamkeit und Nebenwirkungen analysiert. Alle Indikationen für Antidepressiva, von den depressiven Störungen über die Angst- und Zwangsstörungen bis zu den Trauma- und belastungsbezogenen Störungen, werden abgehandelt. Der Schwerpunkt liegt auch in dieser Auflage im praktischen Umgang mit Antidepressiva.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatur

  • Andrews G, Basu A, Cuijpers P et al (2018) Computer therapy for the anxiety and depression disorders is effective, acceptable and practical health care: an updated meta-analysis. J Anxiety Disord 55: 70–78

    Article  CAS  PubMed  Google Scholar 

  • Bandelow B, Sagebiel A, Belz M et al (2018) Enduring effects of psychological treatments for anxiety disorders: meta-analysis of follow-up studies. Br J Psychiatry 212(6):333–338

    Article  PubMed  Google Scholar 

  • Bartels C, Wagner M, Wolfsgruber S et al; Alzheimer’s Disease Neuroimaging Initiative (2018) Impact of SSRI therapy on risk of conversion from mild cognitive impairment to Alzheimer’s dementia in individuals with previous depression. Am J Psychiatry 175(3):232–241

    Article  Google Scholar 

  • Batelaan NM, Bosman RC, Muntingh A et al (2017) Risk of relapse after antidepressant discontinuation in anxiety disorders, obsessive-compulsive disorder, and post-traumatic stress disorder: systematic review and meta-analysis of relapse prevention trials. BMJ 358:j3927

    Article  PubMed  PubMed Central  Google Scholar 

  • Bockting CLH, Klein NS, Elgersma HJ et al (2018) Effectiveness of preventive cognitive therapy while tapering antidepressants versus maintenance antidepressant treatment versus their combination in prevention of depressive relapse or recurrence (DRD study): a three-group, multicentre, randomised controlled trial. Lancet Psychiatry 5(5):401–410

    Article  PubMed  Google Scholar 

  • Boland EM, Rao H, Dinges DF et al (2017) Meta-analysis of the antidepressant effects of acute sleep deprivation. J Clin Psychiatry 78(8):e1020–e1034

    Article  PubMed  Google Scholar 

  • Brännström J, Lövheim H, Gustafson Y et al (2019) Association between antidepressant drug use and hip fracture in older people before and after treatment initiation. JAMA Psychiatry 76(2):172–179

    Article  PubMed  PubMed Central  Google Scholar 

  • Brouwer A, Nguyen HT, Snoek FJ et al (2017) Light therapy: is it safe for the eyes? Acta Psychiatr Scand 136(6):534–548

    Article  CAS  PubMed  Google Scholar 

  • Brunet A, Saumier D, Liu A et al (2018) Reduction of PTSD symptoms with pre-reactivation propranolol therapy: a randomized controlled trial. Am J Psychiatry 175(5):427–433

    Article  PubMed  Google Scholar 

  • Bykov K, Schneeweiss S, Donneyong MM et al (2017) Impact of an interaction between clopidogrel and selective serotonin reuptake inhibitors. Am J Cardiol 119(4):651–657

    Article  CAS  PubMed  Google Scholar 

  • Cipriani A, Furukawa TA, Salanti G et al (2018) Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet 391(10128):1357–1366

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Dakwar E, Nunes EV, Hart CL et al (2019) A single ketamine infusion combined with mindfulness-based behavioral modification to treat cocaine dependence: a randomized clinical trial. Am J Psychiatry 176(11):923–930

    Article  PubMed  Google Scholar 

  • Dakwar E, Levin F, Hart CL et al (2020) A single ketamine infusion combined with motivational enhancement therapy for alcohol use disorder: a randomized midazolam-controlled pilot trial. Am J Psychiatry 177(2):125–133

    Article  PubMed  Google Scholar 

  • DeRubeis RJ, Zajecka J, Shelton RC et al (2019) Depressive episode with antidepressant medication alone or in combination with cognitive behavioral therapy: a phase 2 randomized clinical trial. Jama Psychiatry 77(3):237–245

    Article  PubMed Central  Google Scholar 

  • DGPPN, BÄK, KBV, AWMF, AkdÄ, BPtK, BApK, DAGSHG, DEGAM, DGPM, DGPs, DGRW, Leitliniengruppe Unipolare Depression (2015) S3-Leitlinie/Nationale VersorgungsLeitlinie Unipolare Depression – Langfassung, 2. Aufl. Version 5. https://www.leitlinien.de/nvl/depression. Zugegriffen: 11. März 2018

  • Douros A, Dell’Aniello S, Dehghan G et al (2019) Degree of serotonin reuptake inhibition of antidepressants and ischemic risk: a cohort study. Neurology 93(10):e1010–e1020

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Dragioti E, Solmi M, Favaro A et al (2019) Association of antidepressant use with adverse health outcomes: a systematic umbrella review. JAMA Psychiatry 76(12):1241–1255

    Article  PubMed  PubMed Central  Google Scholar 

  • Dudas R, Malouf R, McCleery J, Dening T (2018) Antidepressants for treating depression in dementia. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD003944.pub2

    Article  PubMed  PubMed Central  Google Scholar 

  • Dunlop BW, LoParo D, Kinkead B et al (2019) Benefits of sequentially adding cognitive-behavioral therapy or antidepressant medication for adults with nonremitting depression. Am J Psychiatry 176(4):275–286

    Article  PubMed  PubMed Central  Google Scholar 

  • Fava GA, Cosci F (2019) Understanding and managing withdrawal syndromes after discontinuation of antidepressant drugs. J Clin Psychiatry 80(6):19com12794

    PubMed  Google Scholar 

  • Fava M, Freeman MP, Flynn M et al (2018) Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD). Mol Psychiatry 25(7):1592–1603

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Fernandes N, Prada L, Rosa MM et al (2020) The impact of SSRIs on mortality and cardiovascular events in patients with coronary artery disease and depression: systematic review and meta-analysis. Clin Res Cardiol. Online ahead of print

    Google Scholar 

  • Firth J, Teasdale SB, Allott K et al (2019) The efficacy and safety of nutrient supplements in the treatment of mental disorders: a meta-review of meta-analyses of randomized controlled trials. World Psychiatry 18(3):308–324

    Article  PubMed  PubMed Central  Google Scholar 

  • FOCUS Trial Collaboration (2019) Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial. Lancet 393(10168):265–274

    Article  Google Scholar 

  • Fu Y, Dai Q, Zhu L, Wu S (2018) Antidepressants use and risk of cataract development: a systematic review and meta-analysis. BMC Ophthalmol 18(1):31

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Furukawa TA, Cipriani A, Cowen PJ et al (2019) Optimal dose of selective serotonin reuptake inhibitors, venlafaxine, and mirtazapine in major depression: a systematic review and dose-response meta-analysis. Lancet Psychiatry 6(7):601–609

    Article  PubMed  PubMed Central  Google Scholar 

  • Gunduz-Bruce H, Silber C, Kaul I et al (2019) Trial of SAGE-217 in patients with major depressive disorder. N Engl J Med 81(10):903–911

    Article  Google Scholar 

  • Henssler J, Heinz A, Brandt L, Bschor T (2019) Antidepressant withdrawal and rebound phenomena. Dtsch Arztebl Int 116(20):355–361

    PubMed  PubMed Central  Google Scholar 

  • Hiemke C, Bergemann N, Clement HW et al (2018) Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017. Pharmacopsychiatry 51(1-02):9–62

    CAS  PubMed  Google Scholar 

  • Hieronymus F, Lisinski A, Nilsson S et al (2019) Influence of baseline severity on the effects of SSRIs in depression: an item-based, patient-level post-hoc analysis. Lancet Psychiatry 6(9):745–752

    Article  PubMed  Google Scholar 

  • Horowitz MA, Taylor D (2019) Tapering of SSRI treatment to mitigate withdrawal symptoms. Lancet Psychiatry 6(6):538–546

    Article  PubMed  Google Scholar 

  • Jakubovski E, Varigonda AL, Freemantle N et al (2016) Systematic review and meta-analysis: dose-response relationship of selective serotonin reuptake inhibitors in major depressive disorder. Am J Psychiatry 173(2):174–183

    Article  PubMed  Google Scholar 

  • Kessler DS, MacNeill SJ, Tallon D (2018) Mirtazapine added to SSRIs or SNRIs for treatment resistant depression in primary care: phase III randomised placebo controlled trial (MIR). BMJ 363: k4218

    Article  PubMed  PubMed Central  Google Scholar 

  • Karyotaki E, Riper H, Twisk J et al (2017) Efficacy of self-guided internet-based cognitive behavioral therapy in the treatment of depressive symptoms: a meta-analysis of individual participant data. JAMA Psychiatry 74(4):351–359

    Article  PubMed  Google Scholar 

  • Khan A, Fahl Mar K, Faucett J et al (2017) Has the rising placebo response impacted antidepressant clinical trial outcome? Data from the US Food and Drug Administration 1987–2013. World Psychiatry 16(2):181–192

    Article  PubMed  PubMed Central  Google Scholar 

  • Köhler-Forsberg O, Lydholm NC, Hjorthøj C et al (2019a) Efficacy of anti-inflammatory treatment on major depressive disorder or depressive symptoms: meta-analysis of clinical trials. Acta Psychiatr Scand 139(5):404–419

    Article  PubMed  CAS  Google Scholar 

  • Köhler-Forsberg O, Gasse C, Petersen L et al (2019b) Statin treatment and the risk of depression. J Affect Disord 246:706–715

    Article  PubMed  CAS  Google Scholar 

  • Kraglund KL, Mortensen JK, Damsbo AG et al (2018) Neuroregeneration and vascular protection by citalopram in acute ischemic stroke (TALOS). Stroke 49(11):2568–2576

    Article  CAS  PubMed  Google Scholar 

  • Kupfer DJ (1991) Long-term treatment of depression. J Clin Psychiatry 52(Suppl 5):28–34

    PubMed  Google Scholar 

  • Lazarov A, Pine DS, Bar-Haim Y (2017) Gaze-contingent music reward therapy for social anxiety disorder: a randomized controlled trial. Am J Psychiatry 174(7):649–656

    Article  PubMed  Google Scholar 

  • Lejoyeux M, Matharan S, de Bodinat C (2015) How to switch to agomelatine after an unsuccessful try with paroxetine or venlafaxine. CNS Spectr 20(1):29–38

    Article  PubMed  Google Scholar 

  • Mataix-Cols D, Fernández de la Cruz L, Monzani B, DCS Anxiety Consortium, Altemus M, Anderson P, Cukor J et al (2017) D-Cycloserine augmentation of exposure-based cognitive behavior therapy for anxiety, obsessive-compulsive, and posttraumatic stress disorders: a systematic review and meta-analysis of individual participant data. Jama Psychiatry 74(5):501–510

    Article  PubMed  Google Scholar 

  • McClintock SM, Reti IM, Carpenter LL et al; National Network of Depression Centers rTMS Task Group; American Psychiatric Association Council on Research Task Force on Novel Biomarkers and Treatments (2018) Consensus recommendations for the clinical application of repetitive transcranial magnetic stimulation (rTMS) in the treatment of depression. J Clin Psychiatry 79(1):16cs10905

    Google Scholar 

  • Meister R, Jansen A, Berger M et al (2018) Psychotherapie depressiver Störungen. Verfahren, Evidenz und Perspektiven. Nervenarzt 89(3):241–251

    Article  CAS  PubMed  Google Scholar 

  • Merz J, Schwarzer G, Gerger H (2019) Comparative efficacy and acceptability of pharmacological, psychotherapeutic, and combination treatments in adults with posttraumatic stress disorder: a network meta-analysis. JAMA Psychiatry 76(9):904–913

    Article  PubMed  PubMed Central  Google Scholar 

  • Orlova Y, Rizzoli P, Loder E (2018) Association of coprescription of triptan antimigraine drugs and selective serotonin reuptake inhibitor or selective norepinephrine reuptake inhibitor antidepressants with serotonin syndrome. JAMA Neurol 75(5):566–572

    Article  PubMed  PubMed Central  Google Scholar 

  • Paulzen M, Haen E, Hiemke C et al (2018) Antidepressant polypharmacy and the potential of pharmacokinetic interactions: Doxepin but not mirtazapine causes clinically relevant changes in venlafaxine metabolism. J Affect Disord 227:506–511

    Article  CAS  PubMed  Google Scholar 

  • Phillips JL, Norris S, Talbot J et al (2019) Single, repeated, and maintenance ketamine infusions for treatment-resistant depression: a randomized controlled trial. Am J Psychiatry 176(5):401–409

    Article  PubMed  Google Scholar 

  • Phillips JL, Norris S, Talbot J et al (2020) Single and repeated ketamine infusions for reduction of suicidal ideation in treatment-resistant depression. Neuropsychopharmacology 45(4):606–612

    Article  CAS  PubMed  Google Scholar 

  • Rauch SAM, Kim HM, Powell C et al (2019) Efficacy of prolonged exposure therapy, sertraline hydrochloride, and their combination among combat veterans with posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry 76(2):117–126

    Article  PubMed  Google Scholar 

  • Reiff CM, Richman EE, Nemeroff CB et al; and the Work Group on Biomarkers and Novel Treatments, a Division of the American Psychiatric Association Council of Research (2020) Psychedelics and psychedelic-assisted psychotherapy. Am J Psychiatry 177(5):391–410

    Article  Google Scholar 

  • Renoux C, Vahey S, Dell’Aniello S, Boivin JF (2017) Association of selective serotonin reuptake inhibitors with the risk for spontaneous intracranial hemorrhage. JAMA Neurol 74(2):173–180

    Article  PubMed  Google Scholar 

  • Rosenblat JD, Carvalho AF, Li M et al (2019) Oral ketamine for depression: a systematic review. J Clin Psychiatry 80(3):18r12475

    Article  PubMed  Google Scholar 

  • Rutten S, Vriend C, Smit JH et al (2019) Bright light therapy for depression in Parkinson disease: a randomized controlled trial. Neurology 92(11):e1145–e1156

    PubMed  Google Scholar 

  • Schäfer I, Gast U, Hofmann A et al (2019) S3-Leitlinie Postraumatische Belastungsstörung. Springer, Berlin Heidelberg New York

    Book  Google Scholar 

  • Schlereth T et al (2019) Diagnose und nicht interventionelle Therapie neuropathischer Schmerzen, S2k-Leitlinie, 2019. In: Deutsche Gesellschaft für Neurologie (Hrsg) Leitlinien für Diagnostik und Therapie in der Neurologie (Online: www.dgn.org/leitlinien (abgerufen am 09.03.2020))

    Google Scholar 

  • Sharma T, Guski LS, Freund N, Gøtzsche PC (2016) Suicidality and aggression during antidepressant treatment: systematic review and meta-analyses based on clinical study reports. BMJ 352:i65

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Slee A, Nazareth I, Bondaronek P et al (2019) Pharmacological treatments for generalised anxiety disorder: a systematic review and network meta-analysis. Lancet 393(10173):768–777

    Article  CAS  PubMed  Google Scholar 

  • Stingl JC, Brockmöller J (2013) Personalisierte Pharmakotherapie. Evidenzbasierte Leitlinien und klinische Anwendung pharmakogenetischer Diagnostik. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 56(11):1509–1521

    Article  CAS  PubMed  Google Scholar 

  • Taylor JH, Landeros-Weisenberger A et al (2018) Ketamine for social anxiety disorder: a randomized, placebo-controlled crossover trial. Neuropsychopharmacology 43(2):325–333

    Article  CAS  PubMed  Google Scholar 

  • Undurraga J, Baldessarini RJ (2017) Direct comparison of tricyclic and serotonin-reuptake inhibitor antidepressants in randomized head-to-head trials in acute major depression: Systematic review and meta-analysis. J Psychopharmacol 31(9):1184–1189

    Article  CAS  PubMed  Google Scholar 

  • Voican CS, Corruble E, Naveau S, Perlemuter G (2014) Antidepressant-induced liver injury: a review for clinicians. Am J Psychiatry 171(4):404–415

    Article  PubMed  Google Scholar 

  • Walther A, Breidenstein J, Miller R (2019) Association of testosterone treatment with alleviation of depressive symptoms in men: a systematic review and meta-analysis. JAMA Psychiatry 76(1):31–40

    Article  PubMed  Google Scholar 

  • Wenzel-Seifert K, Wittmann M, Haen E (2011) QTc prolongation by psychotropic drugs and the risk of Torsades de Pointes. Dtsch Arztebl Int 108(41):687–693

    PubMed  PubMed Central  Google Scholar 

  • Williams NR, Heifets BD, Blasey C et al (2018) Attenuation of antidepressant effects of ketamine by opioid receptor antagonism. Am J Psychiatry 175(12):1205–1215

    Article  PubMed  PubMed Central  Google Scholar 

  • Williams NR, Heifets BD, Bentzley BS et al (2019) Attenuation of antidepressant and antisuicidal effects of ketamine by opioid receptor antagonism. Mol Psychiatry 24(12):1779–1786

    Article  CAS  PubMed  Google Scholar 

  • Wright JH, Owen JJ, Richards D et al (2019) Computer-assisted cognitive-behavior therapy for depression: a systematic review and meta-analysis. J Clin Psychiatry 80(2):18–r12188

    Article  Google Scholar 

  • Yatham MS, Yatham KS, Ravindran AV et al (2019) Do statins have an effect on depressive symptoms? A systematic review and meta-analysis. J Affect Disord 257:55–63

    Article  CAS  PubMed  Google Scholar 

  • Zhou X, Ravindran AV, Qin B et al (2015) Comparative efficacy, acceptability, and tolerability of augmentation agents in treatment-resistant depression: systematic review and network meta-analysis. J Clin Psychiatry 76(4):e487–e498

    Article  PubMed  Google Scholar 

  • Zisook S, Johnson GR, Tal I et al (2019) General predictors and moderators of depression remission: a VAST-D Report. Am J Psychiatry 176(5):348–357

    Article  PubMed  Google Scholar 

  • Zoellner LA, Roy-Byrne PP, Mavissakalian M et al (2019) Doubly randomized preference trial of prolonged exposure versus sertraline for treatment of PTSD. Am J Psychiatry 176(4):287–296

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Berlin, Deutschland

    Dr. med. Francesca Regen

  2. Mainz, Deutschland

    Otto Benkert

Authors
  1. Dr. med. Francesca Regen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Otto Benkert
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Otto Benkert .

Editor information

Editors and Affiliations

  1. ehemals Universitäts-Klinikum Mainz, Mainz, Germany

    Otto Benkert

  2. Klinik für Psychiatrie und Psychotherapie, ehemals Universitäts-Klinikum München Campus Innenstadt, München, Germany

    Hanns Hippius

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Regen, F., Benkert, O. (2021). Antidepressiva. In: Benkert, O., Hippius, H. (eds) Kompendium der Psychiatrischen Pharmakotherapie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-61753-3_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-61753-3_1

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-61752-6

  • Online ISBN: 978-3-662-61753-3

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation